SEARCH

SEARCH BY CITATION

REFERENCES

  • Adlercreutz H. 2002. Phyto-oestrogens and cancer. Lancet Oncol 6:364373.
  • Arts ICW, Weijenberg MP. New training tools for new epidemiologists. Environ Mol Mutagenesis 87:611615.
  • Azqueta A, Collins AR. 2013. The essential comet assay: A comprehensive guide to measuring DNA damage and repair. Arch Toxicol 87:949968.
  • Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, Bigatti MP, Bolognesi C, Cebulska-Wasilewska A, Fabianova E, Fucic A, Hagmar L, Joksic G, Martelli A, Migliore L, Mirkova E, Scarfi MR, Zijno A, Norppa H, Fenech M. 2007. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28:625631.
  • Bonassi S, Norppa H, Ceppi M, Strömberg U, Vermeulen R, Znaor A, Cebulska-Wasilewska A, Fabianova E, Fucic A, Gundy S, Hansteen IL, Knudsen LE, Lazutka J, Rossner P, Sram RJ, Boffetta P. 2008. Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: Results from a pooled cohort study of 22 358 subjects in 11 countries. Carcinogenesis. 29:11781183.
  • Brunekreef B. 2013. Exposure science, the exposome and public health. Environ Mol Mutagenesis 87:596598.
  • Cantor KP, Villanueva CM, Silverman DT, Figueroa JD, Real FX, Garcia-Closas M, Malats N, Chanock S, Yeager M, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castaño-Vinyals G, Samanic C, Rothman N, Kogevinas M. 2010. Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain. Environ Health Perspect 18:15451550.
  • Chadeau-Hyam M, Campanella G, Jombart T, Bottolo L, Portengen L, Vineis P, Liquet B, Vermeulen RCH. Deciphering the complex: Methodological overview of statistical models to derive OMICS-based biomarkers. Environ Mol Mutagenesis 54:542--557.
  • Codd V, Nelson CP, Albrecht E, Mangino M, Deelen J, Buxton JL, Hottenga JJ, Fischer K, Esko T, Surakka I, Broer L, Nyholt DR, Mateo Leach I, Salo P, Hägg S, Matthews MK, Palmen J, Norata GD, O'Reilly PF, Saleheen D, Amin N, Balmforth AJ, Beekman M, de Boer RA, Böhringer S, Braund PS, Burton PR, de Craen AJ, Denniff M, Dong Y, Douroudis K, Dubinina E, Eriksson JG, Garlaschelli K, Guo D, Hartikainen AL, Henders AK, Houwing-Duistermaat JJ, Kananen L, Karssen LC, Kettunen J, Klopp N, Lagou V, van Leeuwen EM, Madden PA, Mägi R, Magnusson PK, Männistö S, McCarthy MI, Medland SE, Mihailov E, Montgomery GW, Oostra BA, Palotie A, Peters A, Pollard H, Pouta A, Prokopenko I, Ripatti S, Salomaa V, Suchiman HE, Valdes AM, Verweij N, Viñuela A, Wang X, Wichmann HE, Widen E, Willemsen G, Wright MJ, Xia K, Xiao X, van Veldhuisen DJ, Catapano AL, Tobin MD, Hall AS, Blakemore AI, van Gilst WH, Zhu H, Consortium C, Erdmann J, Reilly MP, Kathiresan S, Schunkert H, Talmud PJ, Pedersen NL, Perola M, Ouwehand W, Kaprio J, Martin NG, van Duijn CM, Hovatta I, Gieger C, Metspalu A, Boomsma DI, Jarvelin MR, Slagboom PE, Thompson JR, Spector TD, van der Harst P, Samani NJ. 2013. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet. 45:422427.
  • Coggon D, Friesen MD. 1997. Markers of internal dose: Chemical agents. IARC Sci Publ. 142:95101.
  • De Coster S, van Leeuwen DM, Jennen DGJ, Koppen G, Den Hond E, Nelen V, Schoeters G, Baeyens W, van Delft JHM, Kleinjans JCS, van Larebeke N. Gender-specific transcriptomic response to environmental exposure in Flemish adults. Environ Mol Mutagenesis 54:574--588.
  • Fenech M. 2007. Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:10841104.
  • Gammon MD, Santella RM, Neugut AI, Eng SM, Teitelbaum SL, Paykin A, Levin B, Terry MB, Young TL, Wang LW, Wang Q, Britton JA, Wolff MS, Stellman SD, Hatch M, Kabat GC, Senie R, Garbowski G, Maffeo C, Montalvan P, Berkowitz G, Kemeny M, Citron M, Schnabel F, Schuss A, Hajdu S, Vinceguerra V. 2002. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev. 8:677685.
  • Hagmar L, Bonassi S, Strömberg U, Brøgger A, Knudsen LE, Norppa H, Reuterwall C. 1998. Chromosomal aberrations in lymphocytes predict human cancer: A report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 58:41174121.
  • Hood L, Balling R, Auffray C. 2012. Revolutionizing medicine in the 21st century through systems approaches. Biotechnol J 7:9921001.
  • Hood L, Flores M. 2012. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. N Biotechnol. 29:613624.
  • Kaaks R, Riboli E, Sinha R. 1997. Biochemical markers of dietary intake. IARC Sci Publ. 142:103126.
  • Ketchum NS, Michalek JE, Burton JE. 1999. Serum dioxin and cancer in veterans of Operation Ranch Hand. Am J Epidemiol 49:630639.
  • Kyrtopoulos SA. Making sense of OMICS data in population-based environmental health studies. Environ Mol Mutagenesis 54:468--479.
  • Krajcik RA, Borofsky ND, Massardo S, Orentreich N. 2002. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiol Biomarkers Prev 11:15661573.
  • International Agency for Research on Cancer (IARC). 1996. Formaldehyde. IARC Monogr Eval Carcinog Risk Hum 62:217375.
  • Lamar CA, Dorgan JF, Longcope C, Stanczyk FZ, Falk RT, Stephenson HE, Jr. 2003. Serum sex hormones and breast cancer risk factors in postmenopausal women. Cancer Epidemiol Biomarkers Prev 12:380383.
  • Lan Q, Zhang L, Li G, Vermeulen R, Weinberg RS, Dosemeci M, Rappaport SM, Shen M, Alter BP, Wu Y, Kopp W, Waidyanatha S, Rabkin C, Guo W, Chanock S, Hayes RB, Linet M, Kim S, Yin S, Rothman N, Smith MT. 2004. Hematotoxicity in workers exposed to low levels of benzene. Science 306:1774176.
  • Langevin SM, Kelsey KT. 2013. The fate is not always written in the genes: Epigenomics in epidemiologic studies. Environ Mol Mutagenesis 54:533--541.
  • Marcus PM, Vineis P, Rothman N. 2000. NAT2 slow acetylation and bladder cancer risk: A meta-analysis of 22 case-control studies conducted in the general population. Pharmacogenetics. 10:115122.
  • Mardinoglu A, Nielsen J. 2012. Systems medicine and metabolic modelling. J Intern Med 271:142154.
  • Matullo G, Di Gaetano C, Guarrera S. 2013. Next generation sequencing and rare genetic variants: suitability for human population studies and early findings. Environ Mol Mutagenesis 54:518--532.
  • McHale CM, Lan Q, Corso C, Li G, Zhang L, Vermeulen R, Curry JD, Shen M, Turakulov R, Higuchi R, Germer S, Yin S, Rothman N, Smith MT. 2008. Chromosome translocations in workers exposed to benzene. J Natl Cancer Inst Monogr 39:7477.
  • McHale CM, Zhang L, Reuben T, Smith M. 2013. Analysis of the transcriptome in molecular epidemiology studies. Environ Mol Mutagenesis 54:500--517.
  • Moore LE, Karami S, Steinmaus C, Cantor KP. Use of OMIC technologies to study arsenic exposure in human populations. Environ Mol Mutagenesis 54:589--595.
  • Muñoz N, Bosch FX. 1997. Biomarkers for biological agents. IARC Sci Publ 142:127142.
  • Phillips DH, Hewer A, Martin CN, Garner RC, King MM. 1988. Correlation of DNA adduct levels in human lung with cigarette smoking. Nature 336:790792.
  • Pavuk M, Schecter AJ, Akhtar FZ, Michalek JE. 2003. Serum 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) levels and thyroid function in Air Force veterans of the Vietnam War. Ann Epidemiol 13:335343.
  • Riboli E, Lambert R, Kleihues P. 2002. Nutrition and cancer: A complex relationship. IARC Sci Publ 156:34.
  • Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD, Gao YT, Henderson BE. 1992. Urinary aflatoxin Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339:943946.
  • Rothman N, Talaska G, Hayes RB, Bhatnagar VK, Bell DA, Lakshmi VM, Kashyap SK, Dosemeci M, Kashyap R, Hsu FF, Jaeger M, Hirvonen A, Parikh DJ, Davis BB, Zenser TV. 1997. Acidic urine pH is associated with elevated levels of free urinary benzidine and N-acetylbenzidine and urothelial cell DNA adducts in exposed workers. Cancer Epidemiol Biomarkers Prev 6:10391042.
  • Saberi Hosnijeh F, Pechlivanis A, Keun HC, Portengen P, Bueno-de-Mesquita HB, Heederik D, Vermeulen R. 2013. Serum metabolomic pertubations among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Environ Mol Mutagenesis 54:558--565.
  • Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. 2007. Human papillomavirus and cervical cancer. Lancet 370:890907.
  • Schatzkin A, Freedman LS, Schiffman MH, Dawsey SM. 1990. Validation of intermediate end points in cancer research. J Natl Cancer Inst 82:17461752.
  • Spitz MR, Wu X, Mills G. 2005. Integrative epidemiology: From risk assessment to outcome prediction. J Clin Oncol 23:267275.
  • Spitz MR, Bondy ML. 2010. The evolving discipline of molecular epidemiology of cancer. Carcinogenesis 31:127134.
  • Starek A. 2003. Estrogens and organochlorine xenoestrogens and breast cancer risk. Int J Occup Med Environ Health 16:113124.
  • Thomas R, McHale C, Qing L, Hubbard A, Zhang L, Vermeulen Roel, Guilan L, Rappaport S, Yin S, Rothman N, Smith M. Global gene expression response of a population exposed to benzene: A pilot study exploring the use of RNA-sequencing technology. Environ Mol Mutagenesis 54:566--573.
  • Vähäkangas K. Research ethics in the post-genomic era. Environ Mol Mutagenesis 54:599--610.
  • Valdiglesias V, Giunta S, Fenech M, Neri M, Bonassi S. 2013. γH2AX as a marker of DNA double strand breaks and genomic instability in human population studies. Mutat Res. 2013 Feb 13. pii: S1383-5742(13)00023-9. doi: 10.1016/j.mrrev.2013.02.001. [Epub ahead of print].
  • Vineis P, Khan AE, Vlaanderen J, Vermeulen R. 2009. The impact of new research technologies on our understanding of environmental causes of disease: The concept of clinical vulnerability. Environ Health 8:54.
  • Vineis P, van Veldhoven K, Chadeau-Hyam M. Athersuch TJ. Advancing the application of omics-based biomarkers in environmental epidemiology. Environ Mol Mutagenesis 54:461--467.
  • Vlaanderen J, Moore LE, Smith MT, Lan Q, Zhang L, Skibola CF, Rothman N, Vermeulen R. 2009. Application of OMICS technologies in occupational and environmental health research; current status and projections. Occup Environ Med 67:136143.
  • Zhang L, McHale CM, Rothman N, Li G, Ji Z, Vermeulen R, Hubbard AE, Ren X, Shen M, Rappaport SM, North M, Skibola CF, Yin S, Vulpe C, Chanock SJ, Smith MT, Lan Q. 2010. Systems biology of human benzene exposure. Chem Biol Interact 184:8693.
  • Wild CP, Pisani P. 1997. Carcinogen-DNA and carcinogen-protein adducts in molecular epidemiology. IARC Sci Publ 142:143158.
  • Wild CP, Andersson C, O'Brien NM, Wilson L, Woods JA. 2001. A critical evaluation of the application of biomarkers in epidemiological studies on diet and health. Br J Nutr 86:S37S53.
  • Wild CP. 2005 Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 14:1847-1850.
  • Wild CP, Scalbert A, Herceg Z. Measuring the exposome: A powerful basis for evaluating environmental exposures and cancer risk. Environ Mol Mutagenesis 54:480--499.